"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.
作者信息
Messori Andrea, Santarlasci Benedetta, Trippoli Sabrina, Vaiani Monica
出版信息
BMJ. 2003 Oct 4;327(7418):808-9; discussion 809; author reply 809-10. doi: 10.1136/bmj.327.7418.808-c.
Abstract
摘要
相似文献
1
"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.用于对抗心血管疾病的“复方药丸”：他汀类药物用于心血管事件一级预防的成本效益存疑。
BMJ. 2003 Oct 4;327(7418):808-9; discussion 809; author reply 809-10. doi: 10.1136/bmj.327.7418.808-c.
2
Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease.与风险评估相比，复方制剂预防心血管疾病的成本效益分析。
Heart. 2017 Apr;103(7):483-491. doi: 10.1136/heartjnl-2016-310529. Epub 2017 Jan 11.
3
Prescribing statins in general practice: who decides?在全科医疗中开具他汀类药物：由谁来决定？
Br J Gen Pract. 2017 Jun;67(659):246-247. doi: 10.3399/bjgp17X690953.
4
Cost-effectiveness of statins in older adults: further evidence that less is more.他汀类药物在老年人中的成本效益：进一步证明了少即是多。
Ann Intern Med. 2015 Apr 21;162(8):590-1. doi: 10.7326/M15-0535.
5
Cost and effectiveness of cardiovascular prevention.心血管疾病预防的成本与效益
Am J Cardiol. 2007 Nov 1;100(9):1492-4; author reply 1494-5. doi: 10.1016/j.amjcard.2007.06.014. Epub 2007 Jul 18.
6
[Statins in primary prevention - a must for the general practitioner?].[他汀类药物用于一级预防——全科医生的必备之选？]
Praxis (Bern 1994). 2011 Jul 6;100(14):859-60. doi: 10.1024/1661-8157/a000593.
7
Statins for primary prevention in older adults.他汀类药物用于老年人的一级预防。
Ann Intern Med. 2015 Apr 21;162(8):I-28. doi: 10.7326/P15-9012.
8
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States.在美国，用多效药丸对心血管疾病二级预防的成本效果和预算影响建模。
Am Heart J. 2019 Aug;214:77-87. doi: 10.1016/j.ahj.2019.04.020. Epub 2019 May 7.
9
Statins for Primary Prevention in Adults Aged 75 Years or Older.他汀类药物用于75岁及以上成年人的一级预防
Ann Intern Med. 2015 Sep 15;163(6):481. doi: 10.7326/L15-5135-2.
10
Statins for Primary Prevention in Adults Aged 75 Years or Older.他汀类药物用于75岁及以上成年人的一级预防
Ann Intern Med. 2015 Sep 15;163(6):481. doi: 10.7326/L15-5135.
引用本文的文献
1
Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease prevention.经济分析中的效果计算：他汀类药物用于心血管疾病预防的案例
J Epidemiol Community Health. 2006 Oct;60(10):839-45. doi: 10.1136/jech.2005.041251.
2
The polypill: at what price would it become cost effective?多效药丸：达到何种价格才会具有成本效益？
J Epidemiol Community Health. 2006 Mar;60(3):213-7. doi: 10.1136/jech.2005.040253.
本文引用的文献
1
A strategy to reduce cardiovascular disease by more than 80%.一种将心血管疾病减少80%以上的策略。
BMJ. 2003 Jun 28;326(7404):1419. doi: 10.1136/bmj.326.7404.1419.
2
A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries.心血管疾病的治愈方法？联合治疗具有巨大潜力，尤其是在发展中国家。
BMJ. 2003 Jun 28;326(7404):1407-8. doi: 10.1136/bmj.326.7404.1407.
Zotero 插件